Caris Life Sciences vs Xinteza API
Caris Life Sciences vs Xinteza API, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Xinteza API on 42/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 42/100
- agent readiness: 47/100 against 21/100
- domain rating: 62/100 against 1/100
- headcount: 1,659 against 4
- funding raised: $700M against $10.0M
- LinkedIn following: 77,698 against 83
Xinteza API
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Xinteza API |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Biosynthesis of cannabinoids and psychedelics using advanced biotechnology. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Cannabis, Genetics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2008 | 2021 |
| Headquarters | Irving, United States | San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Xinteza API |
|---|---|---|
| Employees | 1,659 | 4 |
| Headcount growthLast 12 months | Not published | +10.4% |
| Total funding | $700M | $10.0M |
| Latest round | Series D | Seed |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 83 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Xinteza API |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 42/100 |
| Traction | 60/100 | 42/100 |
| Team | Not published | 60/100 |
| Search visibility | 22/100 | 18/100 |
| Quality | 78/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Xinteza API |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Analytics | Google Tag Manager | Not detected |
Caris Life Sciences vs Xinteza API: common questions
Which is better, Caris Life Sciences or Xinteza API?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Xinteza API compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 42/100), agent readiness (47/100 against 21/100), domain rating (62/100 against 1/100), headcount (1,659 against 4), funding raised ($700M against $10.0M), LinkedIn following (77,698 against 83).
Read the full Caris Life Sciences review and pricing or the Xinteza API review and pricing. You can also browse other Caris Life Sciences alternatives we track.